United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 26, 2026 · Filed Aug 27, 2026

On Aug 26, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$517.28 for US$4.91M under a trading plan, leaving 324,443 shares. Filed Aug 27, 2026 (Form 4).

Sold
9,500 shares
Price
US$517.28 average (US$514.64 to US$521.48)
Value
US$4.91M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 26, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 26, 2026Common StockSale559US$514.64333,384Indirect
Aug 26, 2026Common StockSale1,591US$515.41331,793Indirect
Aug 26, 2026Common StockSale1,128US$516.70330,665Indirect
Aug 26, 2026Common StockSale3,516US$517.49327,149Indirect
Aug 26, 2026Common StockSale1,790US$518.35325,359Indirect
Aug 26, 2026Common StockSale476US$519.35324,883Indirect
Aug 26, 2026Common StockSale400US$520.62324,483Indirect
Aug 26, 2026Common StockSale40US$521.48324,443Indirect

Source

View original at SEC

Related